Brandinium

Trademark search for:

REXCELNA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2009-04-16 — Application filed
  • 2009-04-20 — Application filed
  • 2009-04-20 — Application filed
  • 2009-05-28 — Assigned to examiner
  • 2009-06-02 — Suspension letter written
  • 2009-06-03 — Letter of suspension mailed
  • 2009-07-29 — Teas response to suspension inquiry received
  • 2009-08-17 — Teas/email correspondence entered
  • 2009-08-17 — Assigned to lie
  • 2009-08-17 — Correspondence received in law office
  • 2009-08-25 — Approved for pub - principal register
  • 2009-09-02 — Approved for pub - principal register
  • 2009-09-02 — Previous allowance count withdrawn
  • 2009-09-02 — Law office publication review completed
  • 2009-09-16 — Notice of publication
  • 2009-10-06 — Published for opposition
  • 2009-12-29 — Noa mailed - sou required from applicant
  • 2010-01-14 — Sou teas extension received
  • 2010-01-14 — Sou extension 1 filed
  • 2010-01-14 — Sou extension 1 granted
  • 2010-11-11 — Sou teas extension received
  • 2010-11-11 — Sou extension 2 filed
  • 2010-11-22 — Case assigned to intent to use paralegal
  • 2010-11-22 — Sou extension 2 granted
  • 2010-11-23 — Notice of approval of extension request mailed
  • 2011-05-06 — Sou teas extension received
  • 2011-05-06 — Sou extension 3 filed
  • 2011-05-09 — Sou extension 3 granted
  • 2011-05-10 — Notice of approval of extension request mailed
  • 2011-10-05 — Sou teas extension received
  • 2011-10-05 — Sou extension 4 filed
  • 2011-10-07 — Sou extension 4 granted
  • 2011-10-08 — Notice of approval of extension request mailed
  • 2012-05-21 — Sou teas extension received
  • 2012-05-21 — Sou extension 5 filed
  • 2012-05-22 — Sou extension 5 granted
  • 2012-05-23 — Notice of approval of extension request mailed
  • 2012-12-07 — Teas petition to amend basis received
  • 2012-12-18 — Assigned to petition staff
  • 2012-12-29 — Notice of allowance cancelled
  • 2013-01-17 — 44(e) petition - granted
  • 2013-01-22 — Case returned to examination
  • 2013-02-06 — Notice of publication
  • 2013-02-26 — Published for opposition
  • 2013-05-14 — Registered-principal register
  • 2013-05-17 — Correction under section 7 - processed
  • 2013-05-17 — Assigned to paralegal
  • 2015-03-11 — Automatic update of assignment of ownership
  • 2015-03-13 — Attorney/dom.rep.revoked and/or appointed
  • 2015-03-13 — Teas revoke/app/change addr of atty/dom rep received
  • 2015-03-18 — Automatic update of assignment of ownership
  • 2015-04-01 — Automatic update of assignment of ownership
  • 2017-09-27 — Automatic update of assignment of ownership
  • 2018-05-14 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2019-12-20 — Cancelled sec. 8 (6-yr)
  • 2019-12-20 — Final status recorded

Owner Information

ELANCO TIERGESUNDHEIT AG
BASEL CH
NOVARTIS TIERGESUNDHEIT AG
4058 BASEL CH
NOVARTIS TIERGESUNDHEIT AG
4058 BASEL CH
NOVARTIS TIERGESUNDHEIT AG
4058 BASEL CH
Novartis AG
Basel CH
Novartis AG
Basel CH
Novartis AG
Basel CH

Correspondent

Robert E. Lee, Jr. Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
UNITED STATES

Filing Details

Filing Date:
2009-04-16
Status Date:
2019-12-20
Category:
Pharmaceuticals
Filing Year:
2009

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.